Lexapro, Escitalopram News

Owing to Safety, Escitalopram Will Remain as the Clinical Gold Standard Treatment, According to a New Report from Decision Resources WALTHAM, Mass., July 15 WALTHAM, Mass.

What are SSRIs? Selective serotonin reuptake inhibitors are a type of antidepressants in which the main purpose is the treatment of depression, anxiety disorders, and some personality disorders.

Lupin Pharmaceuticals, Inc. announced recently that it has received tentative approval for the company's Abbreviated New Drug Application for Escitalopram Oxalate Tablets 10 mg and 20 mg from the FDA.

Mumbai, June 16: Pharma company Lupin on Monday said it has received US regulatory approval for Escitalopram Oxalate tablets, used in the treatment of depressive disorders.

Older adults with dementia who use antipsychotics in the short term are more likely to have a serious event leading to hospitalization or death, a new study found.

Editor's Choice Main Category: Depression Also Included In: Stroke / Neuroprotection Article Date: 27 May 2008 - 13:00 PDT An article published in the May 28 issue of JAMA reports that patients who took the ...

This Week in JAMA JAMA. 2008;299 :2361. Prevention of Poststroke Depression Patients who survive a stroke are at high risk of developing depression.

Two therapies may increase stroke patients' chances of resuming a normal life. The antidepressant drug escitalopram and problem-solving therapy groups may lower the risk of post-stroke depression, new research ...

The annual incidence of stroke exceeds 700,000 in the U.S. with depression developing in more than half of these patients, according to background information in the article.

Stroke victims often succumb to depression in the months following their attack, but taking an antidepressant may reduce that risk, a new study finds.

Agencies Posted online: Thursday , May 15, 2008 at 1315 hrs IST Mumbai, May 15: Pharma major Zydus Cadila on Thursday said it has received approval from the US FDA to market four products, including ...

“Patients suffering from insomnia may have co-existing medical and psychiatric illnesses”

A new study found the use of a particular medication helped individuals suffering from insomnia and generalized anxiety disorder . via Psych Central News

Mumbai : Ahmedabad-based pharma company, Zydus Cadila has received approval from the United States Food and Drug Agency to market the anti-cholestrol pravastatin sodium in tablet form in the US. via Domain-B

“Patients suffering from insomnia may have co-existing medical and psychiatric illnesses”

LUNESTA Study Of Patients With Insomnia And Co-Morbid Generalized Anxiety Disorder Published In Archives Of General Psychiatry Main Category: Anxiety / Stress Also Included In: Psychology / Psychiatry Article ... via MediLexicon

“Treating depression in adolescents can be particularly challenging because few antidepressants have demonstrated efficacy in clinical trials in this population”

Forest Laboratories's study results show Lexapro significantly improved symptoms of depression as compared to placebo treatment and was well tolerated in adolescents, aged 12-17, with major depressive disorder ... via EMaxHealth

Whether such phenomena can be adequately explained in terms of nonlocality and the quantum vacuum or budget tables they involve superphysical forces and states of matter as yet unknown to science is still an ... via The Capital Letter

“There was no evidence of the development of tolerance during treatment in this trial nor withdrawal symptomatology during the discontinuation period”

Augmentation of antidepressant therapy with a hypnotic agent improves sleep, daytime functioning, anxiety, and mood in patients with comorbid insomnia and generalized anxiety disorder , new study findings ... via Rehab Management

The BRITE trial indicated that early changes in frontal EEG brain signals carry information about future clinical response, the company said, reinforcing Aspect's idea that an EEG-based biomarker could help ... via Quamnet

W. Vaughn McCall, MD, MS ; Thomas Roth, PhD ; Kendyl Schaefer, MS ; Robert Rubens, MD, MBA ; James Roach, MD ; Holly Huang, MS ; Ranga Krishnan, MD Arch Gen Psychiatry. via Archives General Psychiatry

H. Lundbeck A/S , the drugmaker struggling to find a successor to the antidepressant Lexapro, fell to a three-year low in Copenhagen trading last month after its chief executive officer unexpectedly resigned. via Bloomberg